1. Volume 62, Issue 5, Pages 745-752 (November 2012)
Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC) 
Fritz H. Schröder, Jonas Hugosson, Sigrid Carlsson, Teuvo Tammela, Liisa Määttänen, Anssi Auvinen, Maciej Kwiatkowski, Franz Recker, Monique J. Roobol 
European Urology 
Volume 62, Issue 5, Pages (November 2012)
DOI: /j.eururo
Copyright © 2012 European Association of Urology Terms and Conditions

2. Fig. 1 Flow diagram of the study.
ERSPC=European Randomized Study of Screening for Prostate Cancer; PCa=prostate cancer.
*Comprising data of four of the eight ERSPC centers: The Netherlands, Sweden, Finland (Tampere), and Switzerland.
$ Percentage of men with M+ PCa that died.
European Urology  , DOI: ( /j.eururo )
Copyright © 2012 European Association of Urology Terms and Conditions

3. Fig. 2
Nelson-Aalen cumulative hazard estimates of M+ prostate cancer (a) overall, (b) at time of diagnosis, and (c) during follow-up.
PCa=prostate cancer.
European Urology  , DOI: ( /j.eururo )
Copyright © 2012 European Association of Urology Terms and Conditions

4. Fig. 3
Rate per person-years of M+ at diagnosis per study arm and by years after randomization.
European Urology  , DOI: ( /j.eururo )
Copyright © 2012 European Association of Urology Terms and Conditions